Wanquan Biotech Renews National High-Tech Enterprise Certification
Hunan Wanquan Yuxiang Biotechnology Co., Ltd., a wholly-owned subsidiary of Zhejiang Yisite Biotechnology Co., Ltd., has once again successfully obtained the National High-Tech Enterprise certification, earning the "High-Tech Enterprise Certificate" (Certificate No.: GR202443000603) issued by the relevant approving authorities. This recognition, following the initial certification in 2021, marks the company's continued innovation and development in the field of biotechnology, which has received high-level national acknowledgment.
The National High-Tech Enterprise certification is an important qualification established by the Chinese government to encourage technological innovation and promote the development of high-tech industries. It imposes stringent requirements on enterprises in areas including core independent intellectual property, technology achievement transformation capacity, R&D organizational management proficiency, and growth indicators. This successful certification not only affirms Hunan Wanquan Yuxiang Biotechnology Co., Ltd.'s technical capabilities and innovative strengths but also provides robust policy support for the future development of its parent company, Zhejiang Yisite Biotechnology Co., Ltd.
Since its establishment, Hunan Wanquan Yuxiang Biotechnology Co., Ltd. has consistently adhered to a technology-driven approach, focusing on research and application in the field of biotechnology. The company boasts a high-caliber R&D team and has established close collaborations with multiple research institutions, dedicated to providing customers with high-quality products and solutions. This renewed National High-Tech Enterprise certification will further motivate the company to increase R&D investment, enhance core competitiveness, and promote technological advancement within the industry.
Moving forward, guided by our philosophy of "Innovation, Pragmatism, Collaboration, and Mutual Benefit," we will continue to deepen our dedication to the biotechnology sector. We are committed to contributing to the advancement of the national high-tech industry while creating greater value for our customers and society at large.
Latest News